Genovis AB (Sweden) Today

GENO Stock  SEK 33.40  0.30  0.91%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Genovis AB is selling for under 33.40 as of the 29th of March 2024; that is 0.91 percent up since the beginning of the trading day. The stock's last reported lowest price was 33.0. Genovis AB has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Genovis AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of April 2022 and ending today, the 29th of March 2024. Click here to learn more.
Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 65.47 M outstanding shares. More on Genovis AB

Moving against Genovis Stock

  0.77XSPRAY XSpray Pharma ABPairCorr
  0.71EGTX Egetis TherapeuticsPairCorr
  0.56VITR Vitrolife ABPairCorr
  0.55NANOFS Nanoform Finland PlcPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Genovis Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Genovis AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genovis AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Genovis AB (GENO) is traded on Stockholm Exchange in Sweden and employs 37 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genovis AB's market, we take the total number of its shares issued and multiply it by Genovis AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genovis AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 65.47 M outstanding shares. Genovis AB has accumulated about 81.31 M in cash with 45.92 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Check Genovis AB Probability Of Bankruptcy
Ownership Allocation
Genovis AB has a total of 65.47 Million outstanding shares. Genovis AB secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Genovis Ownership Details

Genovis Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Genovis AB jumping above the current price in 90 days from now is more than 93.0%. The Genovis AB probability density function shows the probability of Genovis AB stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Genovis AB has a beta of -0.0565. This usually indicates as returns on benchmark increase, returns on holding Genovis AB are expected to decrease at a much lower rate. During the bear market, however, Genovis AB is likely to outperform the market. Additionally, genovis AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 33.4HorizonTargetOdds Above 33.4
6.80%90 days
 33.40 
93.17%
Based on a normal probability distribution, the odds of Genovis AB to move above the current price in 90 days from now is more than 93.0 (This Genovis AB probability density function shows the probability of Genovis Stock to fall within a particular range of prices over 90 days) .

Genovis AB Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Genovis AB market risk premium is the additional return an investor will receive from holding Genovis AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Genovis AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Genovis AB's alpha and beta are two of the key measurements used to evaluate Genovis AB's performance over the market, the standard measures of volatility play an important role as well.

Genovis Stock Against Markets

Picking the right benchmark for Genovis AB stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Genovis AB stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Genovis AB is critical whether you are bullish or bearish towards Genovis AB at a given time. Please also check how Genovis AB's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Genovis AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sync Your Broker Now

   

Sync Your Broker

Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
All  Next Launch Module

Genovis AB Corporate Management

Elected by the shareholders, the Genovis AB's board of directors comprises two types of representatives: Genovis AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genovis. The board's role is to monitor Genovis AB's management team and ensure that shareholders' interests are well served. Genovis AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genovis AB's outside directors are responsible for providing unbiased perspectives on the board's policies.

How to buy Genovis Stock?

Before investing in Genovis AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Genovis AB. To buy Genovis AB stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Genovis AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Genovis AB stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Genovis AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Genovis AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Genovis AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Genovis AB?

The danger of trading Genovis AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Genovis AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Genovis AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Genovis AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genovis AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Genovis Stock analysis

When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Please note, there is a significant difference between Genovis AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genovis AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genovis AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.